Summary

Description (Web site quote)

Glycosan Biosystems holds exclusive worldwide rights to a patent estate, which was licensed from the University of Utah Research Foundation with broad claims to product chemical composition, method of crosslinking, method of preparation, and use of the synthetic extracellular matrix (sECM).

The exclusive sECM technology behind the Glycosan's Extracel™ product line makes several specific applications possible, including:

* in vitro three-dimensional cell culture
* in vitro and in vivo animal models to screen for drug efficacy, safety, and toxicology
* reagents for tissue and cell preservation
* personal-care products

Glycosan also holds a coexclusive license for tissue engineering and cell-therapy applications of Extracel™.